Telix has dosed the first patient in a Phase 3 [...]
CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]
Evogene has reported positive Phase 1 data for microbiome-based therapy [...]
Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]
Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive [...]